Martijn G Scholtemeijer1, Maarten F J Seesing1, Hylke J F Brenkman1, Luuk M Janssen2,3, Richard van Hillegersberg1, Jelle P Ruurda1. 1. Department of Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands. 2. Department of Head and Neck Surgical Oncology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands. 3. Department of Otorhinolaryngology, University Medical Center Utrecht, Utrecht, The Netherlands.
Abstract
BACKGROUND: Recurrent laryngeal nerve (RLN) injury caused by esophagectomy may lead to postoperative morbidity, however data on long-term recovery are scarce. The aim of this study was to evaluate the consequences of RLN palsy (RLNP) in terms of pulmonary morbidity and long-term functional recovery. METHODS: Patients who underwent a 3-stage transthoracic (McKeown) or a transhiatal esophagectomy for esophageal carcinoma in the University Medical Center Utrecht (UMCU) between January 2004 and March 2016 were included from a prospective database. Multivariable analyses were conducted to assess the association between RLNP and pulmonary complications and hospital stay. Data regarding long-term recovery were summarized using descriptive statistics. RESULTS: Out of the 451 included patients, 47 (10%) were diagnosed with RLNP. Of the patients with RLNP, 34 (7%) had a unilateral lesion, 8 (2%) had a bilateral lesion, and in 5 (1%) the location of the lesion was unknown. The incidence of RLNP was 3/127 (2%) in the transhiatal group, and 44/324 (14%) in the McKeown group. RLNP after McKeown esophagectomy was associated with a higher incidence of pulmonary complications (OR 2.391; 95% CI 1.222-4.679; P=0.011), as well as a longer hospital stay (+4 days) (P=0.001). Of the RLNP patients with more than 6 months follow up almost half recovered fully {median follow-up of 17.5 [7-135] months}. Of the remainder, six required a surgical intervention and the others had residual symptoms. CONCLUSIONS: RLNP after McKeown esophagectomy is associated with an increased pulmonary complication rate, longer hospital stay, and a moderate long-term recovery. Further studies are necessary that examine technologies, which may reduce RLNP incidence and contribute to the early detection and treatment of RLNP.
BACKGROUND: Recurrent laryngeal nerve (RLN) injury caused by esophagectomy may lead to postoperative morbidity, however data on long-term recovery are scarce. The aim of this study was to evaluate the consequences of RLN palsy (RLNP) in terms of pulmonary morbidity and long-term functional recovery. METHODS:Patients who underwent a 3-stage transthoracic (McKeown) or a transhiatal esophagectomy for esophageal carcinoma in the University Medical Center Utrecht (UMCU) between January 2004 and March 2016 were included from a prospective database. Multivariable analyses were conducted to assess the association between RLNP and pulmonary complications and hospital stay. Data regarding long-term recovery were summarized using descriptive statistics. RESULTS: Out of the 451 included patients, 47 (10%) were diagnosed with RLNP. Of the patients with RLNP, 34 (7%) had a unilateral lesion, 8 (2%) had a bilateral lesion, and in 5 (1%) the location of the lesion was unknown. The incidence of RLNP was 3/127 (2%) in the transhiatal group, and 44/324 (14%) in the McKeown group. RLNP after McKeown esophagectomy was associated with a higher incidence of pulmonary complications (OR 2.391; 95% CI 1.222-4.679; P=0.011), as well as a longer hospital stay (+4 days) (P=0.001). Of the RLNP patients with more than 6 months follow up almost half recovered fully {median follow-up of 17.5 [7-135] months}. Of the remainder, six required a surgical intervention and the others had residual symptoms. CONCLUSIONS: RLNP after McKeown esophagectomy is associated with an increased pulmonary complication rate, longer hospital stay, and a moderate long-term recovery. Further studies are necessary that examine technologies, which may reduce RLNP incidence and contribute to the early detection and treatment of RLNP.
Authors: Johan L Dikken; Valery E Lemmens; Michel W J M Wouters; Bas P Wijnhoven; Peter D Siersema; Grard A Nieuwenhuijzen; Johanna W van Sandick; Annemieke Cats; Marcel Verheij; Jan Willem Coebergh; Cornelis J H van de Velde Journal: Eur J Cancer Date: 2012-02-06 Impact factor: 9.162
Authors: Pieter C van der Sluis; Roy J J Verhage; Sylvia van der Horst; Willem M van der Wal; Jelle P Ruurda; Richard van Hillegersberg Journal: Dig Surg Date: 2014-06-05 Impact factor: 2.588
Authors: Christopher P Wang; Michael P Rogers; Gregory Bach; Joseph Sujka; Rahul Mhaskar; Christopher DuCoin Journal: Surg Endosc Date: 2021-04-06 Impact factor: 4.584
Authors: Yeong Jeong Jeon; Jong Ho Cho; Hong Kyu Lee; Hong Kwan Kim; Yong Soo Choi; Jae Ill Zo; Young Mog Shim Journal: Thorac Cancer Date: 2021-05-06 Impact factor: 3.500